Filing Details
- Accession Number:
- 0001628280-22-025099
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2022-09-19 08:37:06
- Reporting Period:
- 2022-09-16
- Accepted Time:
- 2022-09-19 08:37:06
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1213037 | Cardiff Oncology Inc. | CRDF | Biological Products, (No Disgnostic Substances) (2836) | 272004382 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1463151 | E. James Levine | C/O Cardiff Oncology, Inc. 11055 Flintkote Ave San Diego CA 92121 | Chief Financial Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2022-09-16 | 30,000 | $1.56 | 60,000 | No | 4 | P | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | P | Direct |
Footnotes
- The price reported in Column 4 is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $1.555 to $1.56. Full information regarding the number of shares purcahsed at each separate price can be furnished to the SEC staff upon request.